Evidence-based obesity treatment
Obesity treatment that treats it like a disease
Obesity is a chronic medical condition — not a willpower problem. Modern treatment reflects that: physician-managed GLP-1 medication combined with lifestyle change now achieves results once only seen with surgery.
Last clinically reviewed: July 16, 2026 by Dr. Prajeet Reddy, MD (Medical Director)
$29/mo membership · no contracts · no charge if not prescribed
FDA-approved options through Imbue
Once-weekly injection (single-use vial + syringe)
22% avg. weight loss in trials* · $328/mo all-in with membership
Once-weekly injection (pre-filled pen)
15% avg. weight loss in trials* · $228/mo all-in with membership
Once-daily oral pill — no food or water restrictions
11% avg. weight loss in trials* · $178/mo all-in with membership
*Average results from clinical trials of adults with BMI ≥30, or ≥25 with weight-related conditions, alongside diet and exercise. Individual results vary. Medication purchased separately at manufacturer cash-pay pricing.
The treatment landscape, honestly
Lifestyle change alone typically produces 3–5% sustained weight loss — meaningful, but rarely sufficient for obesity. Bariatric surgery produces 25–30% but is invasive and irreversible. GLP-1 medications now sit between: 11%–22% average weight loss in trials, non-surgically, with treatment that adjusts as your needs change.
The medical consensus has shifted: obesity is a chronic disease involving hormonal appetite regulation, and like hypertension or diabetes, it responds to ongoing medical treatment — not short courses or cycles of willpower.
What treatment through Imbue involves
A licensed physician reviews your health history and prescribes the FDA-approved medication that fits it — then manages your treatment continuously: gradual dose escalation, side-effect management, and adjustments over time. Medication ships from NovoCare or LillyDirect; nutrition and activity guidance support the medication's effect on appetite.
Eligibility generally begins at BMI 30, or 25+ with a weight-related condition such as hypertension, prediabetes, or sleep apnea.
Frequently asked questions
Is obesity really a disease?
Yes — the AMA classified obesity as a chronic disease in 2013, and the biology supports it: hormonal appetite regulation, metabolic adaptation that resists weight loss, and high relapse without ongoing treatment. That's why modern care treats it like other chronic conditions.
Do I need surgery to treat obesity?
Usually not anymore. GLP-1 medications reached 22% average weight loss in trials — approaching surgical outcomes for many patients — without an operation. Surgery remains an option for severe cases; your physician can discuss both paths.
What happens if I stop treatment?
As with any chronic disease, stopping treatment usually means the condition returns — trials show most weight regained within a year of discontinuing. Obesity medicine increasingly treats GLP-1s as long-term therapy, like blood-pressure medication.
What does medical obesity treatment cost?
Through Imbue: $29/month for physician care plus medication from $149/month at manufacturer prices — $178–$478/month all-in depending on medication and dose. No insurance required.
See if you qualify — free
A licensed physician reviews your health history, usually within 48 hours. $29/mo membership only if prescribed — the lowest fee in GLP-1 telehealth. Cancel anytime.